ARMI Revenue and Competitors

Manchester, NH USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ARMI's estimated annual revenue is currently $15.8M per year.(i)
  • ARMI's estimated revenue per employee is $155,000

Employee Data

  • ARMI has 102 Employees.(i)
  • ARMI grew their employee count by 31% last year.

ARMI's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
Managing Director, BioFab Startup LabReveal Email/Phone
3
Director Strategic PartnershipsReveal Email/Phone
4
Director & Head HRReveal Email/Phone
5
Chief Strategy Officer // Tissue Engineering & Regenerative MedicineReveal Email/Phone
6
Director, Technology and Process DevelopmentReveal Email/Phone
7
Data ScientistReveal Email/Phone
8
Chief Operating OfficerReveal Email/Phone
9
Chief Technology OfficerReveal Email/Phone
10
Chief Innovation OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M681%N/AN/A
#2
$4.3M284%N/AN/A
#3
$2M138%N/AN/A
#4
$1.1M70%N/AN/A
#5
$3.7M24-11%N/AN/A
#6
$1.1M70%N/AN/A
#7
$45.3M292-9%N/AN/A
#8
$1.4M90%N/AN/A
#9
$2M138%N/AN/A
#10
$7M45-34%N/AN/A
Add Company

What Is ARMI?

The BioFabUSA program is a public-private partnership between the Department of Defense (DoD) and the Advanced Regenerative Manufacturing Institute (ARMI), a member driven non-profit organization, whose mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. Within the last decade, significant breakthroughs in cell biology, biofabrication and materials science have laid the foundation for the large-scale manufacturing and commercialization of engineered tissues. However, the field of tissue engineering remains fragmented and lacks a mechanistic framework through which to translate laboratory discovery into manufactured products. The goal of the institute is to close the gap in focus that inhibits the commercialisation and translation of research and development. By removing existing regulatory hurdles, producing scalable GMP-compliant manufacturing processes, and establishing a commercial ecosystem, ARMI will help catalyze and foster the development of a new industry.

keywords:N/A

N/A

Total Funding

102

Number of Employees

$15.8M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ARMI News

2022-04-20 - Usa: le armi sono la prima causa di morte fra i teenagers americani

Secondo l'indagine, pubblicata questa settimana nel New England Journal Medicine, l'incremento delle morti legate alle armi tra gli americani di...

2022-04-20 - Le armi in America sono una piaga

Le armi sono diventata la prima causa di morte dei bambini e dei teenager americani nel 2020, superando gli incidenti d'auto: è quanto...

2022-04-20 - Sono le armi da fuoco la prima causa di morte dei bambini negli Usa

Il team, guidato da Jason Goldstick, Rebecca Cunningham e Patrick Carter, ha valutato il numero di morti associate alle armi da fuoco tra...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.5M10211%N/A
#2
$7.5M10213%N/A
#3
$21.4M10213%N/A
#4
$21.4M1024%N/A
#5
$27.8M10310%N/A